The Cardlytics, Inc. (NASDAQ:CDLX) is going down by -4.00% in today’s trading session, a fall equivalent to -1.3% of the stock’s price from yesterday’s market close. A news came out on 08/08/19 stating that Cardlytics Announces Second Quarter 2019 Financial Results by WSJ. The lowest point that the shares touched during the trading session was $32.05, while the peak of the day was recorded at a share price of $33.99. CDLX finished the previous session at $32.53 according to the data provided by Barchart, while the trading volume was observed to be $753,006.
In the 100 days of trading, CDLX managed to top a 23.73% Moving average. Additionally, Cardlytics, Inc. shares have achieved a 52-week range between 9.80 and 34.64 alongside 100 days raw stochastic set at 84.88%.
The number of shares outstanding, according to the fundamentals of the company, is set at 22.36M, equal to the value of $727.37M in market capitalization. Financial analysts indicate that CDLX shares should be still ranked as a “Outperform”. In the last 30 days, Cardlytics, Inc. shares went down by -8.95%, adding 34.64 to growth in value, on top of a +20.98% boost since 07/22/19.
Cardlytics, Inc. (NASDAQ:CDLX) Analyst’s Estimates
Cardlytics, Inc. (CDLX) could record at least -$0.14 per share in quarterly earnings in the upcoming report on 11/12/2019, a number that would actually represent an increase of 75.40% YOY.
According to the average analyst rating, Cardlytics, Inc. would be rated as 1.57. Out of 7 different analysts monitoring CDLX stock, 3 analysts rate the stock as a BUY, 0 suggest to give the rating of HOLD, 4 indicate that CDLX is an OUTPERFORM, 0 rated the stock as a SELL, and 0 analyst believes that the stock should be rated as UNDERPERFORM.
On Aug-09-19, the stock earned a Downgrade rating due to a new analyst call from KeyBanc Capital Markets, while analysts from BofA/Merrill believe that the stock is set at Buy, as concluded on Jul-24-19. William Blair, is still rather wary about the stock, deciding to keep the rating at Outperform as confirmed through a call on Jul-01-19.
CDLX Key Ratios To Watch:
Taking in account the profitability of the Company, gross profit margin of +41.17% has been attained, while the operating margin has been recorded at -27.15%. The firm is also showcasing profitability through returns on assets in the company’s ownership, with ROA set at -41.68%. Additionally, Cardlytics, Inc. is recording price volatility of 5.57% for the period of the last seven days and 5.87% in the last 30 days.
Cardlytics, Inc. (NASDAQ:CDLX) Technical Outlook
For the period of the last 50 days, Cardlytics, Inc. had its Raw Stochastic average set at 74.04% for the latest technical analysis. In comparison to the period of the last 20 days, the present Raw Stochastic average for the last 50 days poses as improvement, set at 63.83%. Stochastic %K for Cardlytics, Inc., with the last 20 days included, was set at 71.41%, having Stochastic %D topping 76.12%. Based on the previous performance of the company for the mentioned period, there are more than several recorded moving trends. When it comes to the period of the last 12 months, accounting the time for year-to-date, price performance appears to be encouraging for Cardlytics, Inc. stocks with recording 76.51% in metrics.
Cardlytics, Inc. Insider Watch:
As far as the position of shares issued by Cardlytics, Inc. (NASDAQ:CDLX) for the period concluded at the market close of 08/21/19, 56 institutional investors increased their positions in CDLX shares by 5,348,895, 27 decreased positions by 2,856,213 and 5 institutional investors decided to hold positions at 10,689,104. These numbers put the complete list of institutional holdings set at 18,894,212 shares, in accordance with filings submitted to the Securities and Exchange Commission. The stock had another 24 institutional investments with 3,596,365 new shares in addition to having 10 institutional investors selling their positions in 685,172 shares.